Literature DB >> 15908371

Killing of dsrA mutants of Haemophilus ducreyi by normal human serum occurs via the classical complement pathway and is initiated by immunoglobulin M binding.

Malikah Abdullah1, Igor Nepluev, Galyna Afonina, Sanjay Ram, Peter Rice, William Cade, Christopher Elkins.   

Abstract

Previously, we showed that serum resistance in Haemophilus ducreyi type strain 35000HP required expression of the outer membrane protein DsrA because the isogenic dsrA mutant FX517 is highly serum susceptible. In this study, we confirmed this finding by construction of additional serum-susceptible dsrA mutants in more recently isolated serum-resistant strains. We also demonstrated that killing of dsrA mutants required an intact classical complement cascade but not the alternative or mannan-binding lectin pathways. Between 5- and 10-fold more purified human immunoglobulin M (IgM) but not IgG was deposited onto dsrA mutant FX517 than onto parent strain 35000HP, consistent with IgM initiation of the classical cascade. Depletion of IgM, but not IgG, from complement-intact serum inhibited killing of FX517. As predicted from the amounts of IgM bound, more of the individual complement components were bound by FX517 than by parent strain 35000HP. Examination of the binding of negative regulators of complement as an explanation for serum resistance indicated that parent strain 35000HP bound more C4 binding protein and vitronectin than FX517 but not factor H. However, the degree and pattern of complement component binding observed suggested that IgM binding to the serum-susceptible mutant FX517 was responsible for the activation of the classical pathway and the observed killing of FX517 as opposed to binding of negative regulators of complement by the serum-resistant parent. We speculate that an undefined neo-epitope, possibly carbohydrate, is exposed in the dsrA mutant that is recognized by naturally occurring bactericidal IgM antibodies present in human sera.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15908371      PMCID: PMC1111860          DOI: 10.1128/IAI.73.6.3431-3439.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

Review 1.  Complement. First of two parts.

Authors:  M J Walport
Journal:  N Engl J Med       Date:  2001-04-05       Impact factor: 91.245

Review 2.  C4bp binding to porin mediates stable serum resistance of Neisseria gonorrhoeae.

Authors:  S Ram; M Cullinane; A M Blom; S Gulati; D P McQuillen; R Boden; B G Monks; C O'Connell; C Elkins; M K Pangburn; B Dahlbäck; P A Rice
Journal:  Int Immunopharmacol       Date:  2001-03       Impact factor: 4.932

3.  Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.

Authors:  T Lagergård; A Frisk; M Purvèn; L A Nilsson
Journal:  Microb Pathog       Date:  1995-01       Impact factor: 3.738

4.  The Haemophilus ducreyi serum resistance antigen DsrA confers attachment to human keratinocytes.

Authors:  Leah E Cole; Thomas H Kawula; Kristen L Toffer; Christopher Elkins
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

5.  The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi.

Authors:  J Hellwage; T Meri; T Heikkilä; A Alitalo; J Panelius; P Lahdenne; I J Seppälä; S Meri
Journal:  J Biol Chem       Date:  2000-12-11       Impact factor: 5.157

6.  Bordetella pertussis binds to human C4b-binding protein (C4BP) at a site similar to that used by the natural ligand C4b.

Authors:  K Berggård; G Lindahl; B Dahlbäck; A M Blom
Journal:  Eur J Immunol       Date:  2001-09       Impact factor: 5.532

7.  Haemophilus ducreyi lipooligosaccharide mutant defective in expression of beta-1,4-glucosyltransferase is virulent in humans.

Authors:  R S Young; M J Filiatrault; K R Fortney; A F Hood; B P Katz; R S Munson; A A Campagnari; S M Spinola
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

8.  DsrA-deficient mutant of Haemophilus ducreyi is impaired in its ability to infect human volunteers.

Authors:  C T Bong; R E Throm; K R Fortney; B P Katz; A F Hood; C Elkins; S M Spinola
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

9.  The human complement regulator factor H binds pneumococcal surface protein PspC via short consensus repeats 13 to 15.

Authors:  Thomas G Duthy; Rebecca J Ormsby; Eleni Giannakis; A David Ogunniyi; Uwe H Stroeher; James C Paton; David L Gordon
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

10.  A novel lectin, DltA, is required for expression of a full serum resistance phenotype in Haemophilus ducreyi.

Authors:  Isabelle Leduc; Patricia Richards; Crystal Davis; Birgit Schilling; Christopher Elkins
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

View more
  19 in total

1.  Sialylation of lipooligosaccharides is dispensable for the virulence of Haemophilus ducreyi in humans.

Authors:  Stanley M Spinola; Wei Li; Kate R Fortney; Diane M Janowicz; Beth Zwickl; Barry P Katz; Robert S Munson
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

2.  Outer membrane protein DsrA is the major fibronectin-binding determinant of Haemophilus ducreyi.

Authors:  Isabelle Leduc; C Dinitra White; Igor Nepluev; Robert E Throm; Stanley M Spinola; Christopher Elkins
Journal:  Infect Immun       Date:  2008-01-22       Impact factor: 3.441

3.  The Haemophilus ducreyi trimeric autotransporter adhesin DsrA protects against an experimental infection in the swine model of chancroid.

Authors:  William G Fusco; Neelima R Choudhary; Patty A Routh; Melissa S Ventevogel; Valerie A Smith; Gary G Koch; Glen W Almond; Paul E Orndorff; Gregory D Sempowski; Isabelle Leduc
Journal:  Vaccine       Date:  2014-05-18       Impact factor: 3.641

4.  Deletion of mtrC in Haemophilus ducreyi increases sensitivity to human antimicrobial peptides and activates the CpxRA regulon.

Authors:  Sherri D Rinker; Michael P Trombley; Xiaoping Gu; Kate R Fortney; Margaret E Bauer
Journal:  Infect Immun       Date:  2011-03-28       Impact factor: 3.441

5.  Defining Potential Vaccine Targets of Haemophilus ducreyi Trimeric Autotransporter Adhesin DsrA.

Authors:  William G Fusco; Neelima R Choudhary; Shelley M Stewart; S Munir Alam; Gregory D Sempowski; Christopher Elkins; Isabelle Leduc
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2015-04

6.  Prc contributes to Escherichia coli evasion of classical complement-mediated serum killing.

Authors:  Chin-Ya Wang; Shainn-Wei Wang; Wen-Chun Huang; Kwang Sik Kim; Nan-Shan Chang; Ying-Hsiang Wang; Meng-Hsing Wu; Ching-Hao Teng
Journal:  Infect Immun       Date:  2012-07-23       Impact factor: 3.441

7.  A DltA mutant of Haemophilus ducreyi Is partially attenuated in its ability to cause pustules in human volunteers.

Authors:  Diane Janowicz; Isabelle Leduc; Kate R Fortney; Barry P Katz; Christopher Elkins; Stanley M Spinola
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

8.  Trimeric autotransporter DsrA is a major mediator of fibrinogen binding in Haemophilus ducreyi.

Authors:  William G Fusco; Christopher Elkins; Isabelle Leduc
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

9.  Dysregulated immune profiles for skin and dendritic cells are associated with increased host susceptibility to Haemophilus ducreyi infection in human volunteers.

Authors:  Tricia L Humphreys; Lang Li; Xiaoman Li; Diane M Janowicz; Kate R Fortney; Qianqian Zhao; Wei Li; Jeanette McClintick; Barry P Katz; David S Wilkes; Howard J Edenberg; Stanley M Spinola
Journal:  Infect Immun       Date:  2007-09-24       Impact factor: 3.441

10.  Localization of the domains of the Haemophilus ducreyi trimeric autotransporter DsrA involved in serum resistance and binding to the extracellular matrix proteins fibronectin and vitronectin.

Authors:  Isabelle Leduc; Bonnie Olsen; Christopher Elkins
Journal:  Infect Immun       Date:  2008-11-17       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.